GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Health Catalyst Inc (NAS:HCAT) » Definitions » EV-to-EBITDA

Health Catalyst (Health Catalyst) EV-to-EBITDA

: -3.88 (As of Today)
View and export this data going back to 2019. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Health Catalyst's enterprise value is $265.1 Mil. Health Catalyst's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-68.3 Mil. Therefore, Health Catalyst's EV-to-EBITDA for today is -3.88.

The historical rank and industry rank for Health Catalyst's EV-to-EBITDA or its related term are showing as below:

HCAT' s EV-to-EBITDA Range Over the Past 10 Years
Min: -37.05   Med: -14.43   Max: -2.55
Current: -3.91

During the past 7 years, the highest EV-to-EBITDA of Health Catalyst was -2.55. The lowest was -37.05. And the median was -14.43.

HCAT's EV-to-EBITDA is ranked worse than
100% of 459 companies
in the Healthcare Providers & Services industry
Industry Median: 12.81 vs HCAT: -3.91

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-19), Health Catalyst's stock price is $5.58. Health Catalyst's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.100. Therefore, Health Catalyst's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Health Catalyst EV-to-EBITDA Historical Data

The historical data trend for Health Catalyst's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Health Catalyst Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Premium Member Only Premium Member Only -23.18 -21.10 -17.38 -5.48 -6.90

Health Catalyst Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.48 -5.78 -6.52 -6.61 -6.90

Competitive Comparison

For the Health Information Services subindustry, Health Catalyst's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Health Catalyst EV-to-EBITDA Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Health Catalyst's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Health Catalyst's EV-to-EBITDA falls into.



Health Catalyst EV-to-EBITDA Calculation

Health Catalyst's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=265.149/-68.281
=-3.88

Health Catalyst's current Enterprise Value is $265.1 Mil.
Health Catalyst's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-68.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Health Catalyst  (NAS:HCAT) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Health Catalyst's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=5.58/-2.100
=At Loss

Health Catalyst's share price for today is $5.58.
Health Catalyst's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.100.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Health Catalyst EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Health Catalyst's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Health Catalyst (Health Catalyst) Business Description

Traded in Other Exchanges
Address
10897 South River Front Parkway, Suite 300, South Jordan, UT, USA, 84095
Health Catalyst Inc is engaged in providing data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, which is the key revenue driver, includes data platform, analytics applications and support services. This generates revenues primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; and Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
Executives
Linda Llewelyn officer: Chief People Officer C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Jason Alger officer: Chief Accounting Officer C/O HEALTH CATALYST, 3165 MILLROCK DR #400, SALT LAKE CITY UT 84121
Benjamin Landry officer: General Counsel C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Matthew Kolb director C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Bryan Truman Hunt officer: Chief Financial Officer C/O HEALTH CATALYST, 3165 MILLROCK DR #400, SALT LAKE CITY UT 84121
Daniel D. Burton director, officer: Chief Executive Officer C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Anne Marie Bickmore officer: COO and Chief Product Officer C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Kevin Lee Freeman officer: Chief Growth Officer C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Daniel H. Orenstein officer: General Counsel 311 ARSENAL STREET, WATERTOWN MA 02472
Duncan Gallagher director C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Paul Horstmeier officer: Chief Operating Officer C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Bryan Richard Hinton officer: Chief Technology Officer C/O HEALTH CATALYST, 10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN UT 84095
Nelli James Patrick Jr. officer: Chief Financial Officer C/O HEALTH CATALYST, INC., 3165 E.MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Anita Pramoda director 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Timothy G. Ferris director C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE, #400, SALT LAKE CITY UT 84121